Compare HCA Health Inc (HCA) vs Spotify Technology (SPOT) Price & Performance

HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.

The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.

Spotify (SPOT) trades at $526.42, up 7.84% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $15.7B to $17.2B in 2025 and net income surging to $2.2B. Recent Q2 2026 earnings missed expectations, but analyst consensus remains strongly bullish with a $610 price target. Technical indicators show support at $497 and resistance at $524, with the stock approaching key resistance levels.

Spotify presents a compelling growth story with expanding profit margins and strong cash flow generation. The primary investment opportunity lies in continued subscriber growth and margin expansion, though risks include competitive pressures in streaming and execution challenges. Wall Street maintains strong conviction with 62% buy ratings, suggesting 16% upside to consensus targets.